These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of 5-fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG-IIIb cells. Kashima N; Ueda M; Kanazawa J Cancer Sci; 2003 Sep; 94(9):821-5. PubMed ID: 12967482 [TBL] [Abstract][Full Text] [Related]
5. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells. Yasumatsu R; Nakashima T; Uryu H; Masuda M; Hirakawa N; Shiratsuchi H; Tomita K; Fukushima M; Komune S Oral Oncol; 2009 Feb; 45(2):141-7. PubMed ID: 18620897 [TBL] [Abstract][Full Text] [Related]
7. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil. Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143 [TBL] [Abstract][Full Text] [Related]
8. Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil. Kobuchi S; Hayashi A; Taniguchi M; Ito Y; Tamura T; Sakaeda T Cancer Chemother Pharmacol; 2016 Sep; 78(3):517-23. PubMed ID: 27417318 [TBL] [Abstract][Full Text] [Related]
9. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer. Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370 [TBL] [Abstract][Full Text] [Related]
11. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer. Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280 [TBL] [Abstract][Full Text] [Related]
12. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. Miyazaki K; Shibahara T; Sato D; Uchida K; Suzuki H; Matsui H; Yanaka A; Nakahara A; Matsuzaki Y J Gastroenterol; 2006 Feb; 41(2):140-50. PubMed ID: 16568373 [TBL] [Abstract][Full Text] [Related]
13. The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology. Diasio RB Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):23-7. PubMed ID: 9830621 [TBL] [Abstract][Full Text] [Related]
14. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer]. Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726 [TBL] [Abstract][Full Text] [Related]
15. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine. Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816 [TBL] [Abstract][Full Text] [Related]
16. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation. Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Humerickhouse RA; Dolan ME; Haraf DJ; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain MJ; Vokes EE Clin Cancer Res; 1999 Feb; 5(2):291-8. PubMed ID: 10037177 [TBL] [Abstract][Full Text] [Related]
18. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Von Bültzingslöwen I; Adlerberth I; Wold AE; Dahlén G; Jontell M Oral Microbiol Immunol; 2003 Oct; 18(5):278-84. PubMed ID: 12930518 [TBL] [Abstract][Full Text] [Related]
19. Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase. Haaz MC; Fischel JL; Formento P; Renée N; Etienne MC; Milano G Cancer Chemother Pharmacol; 1996; 38(1):52-8. PubMed ID: 8603452 [TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells. Noguchi T; Tanimoto K; Shimokuni T; Ukon K; Tsujimoto H; Fukushima M; Noguchi T; Kawahara K; Hiyama K; Nishiyama M Clin Cancer Res; 2004 Oct; 10(20):7100-7. PubMed ID: 15501990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]